EYPT EyePoint, Inc. - Common Stock
EyePoint, Inc. - Common Stock について Wikipediaからの企業概要
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
続きを読む
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
EYPT 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
EYPT 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
成長 収益、EPS、純利益の成長率:前年比、3年CAGR、5年CAGR
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
EYPT アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
- 強い買い 7 35.0%
- 買い 12 60.0%
- 保有 1 5.0%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
13 アナリスト · 2026-08-19決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $-1.09 | $-0.97 | -0.12% |
| 2026年3月31日 | $-0.99 | $-0.82 | -0.17% |
| 2025年12月31日 | $-0.81 | $-0.76 | -0.05% |
| 2025年9月30日 | $-0.85 | $-0.80 | -0.05% |
| 2025年6月30日 | $-0.85 | $-0.81 | -0.04% |
| 2025年3月31日 | $-0.65 | $-0.67 | 0.02% |
同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
| SPTX | — | — | — | — | — | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| OMER | $1.23B | -343.6 | — | — | 1.9% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
貸借対照表 27
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
キャッシュフロー 18
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
効率性 1
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
成長率 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
バリュエーション(TTM) 14
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
損益計算書 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
貸借対照表 27
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
キャッシュフロー 14
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
流動性と支払能力 5
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
効率性 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
バリュエーション(TTM) 14
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $31M | $43M | $46M | $41M | $37M |
| 営業利益率 % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| 純利益 | $-232M | $-131M | $-71M | $-102M | $-58M |
| 希薄化後EPS | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | — | — | 0.0 | 0.4 | 0.2 |
| 流動比率 | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| クイックレシオ | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $-243M | $-130M | $-2M | $-67M | $-50M |
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家(13F) 217 提出者 · $1.2B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 37 (-18 前期比) | 20 (-3 前期比) | 63 (-9 前期比) | 56 (+18 前期比) | +8.5M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118,638,163 | 8,296,375 | 10.19% | 株式数 |
| Cormorant Asset Management, LP | $100,100,000 | 7,000,000 | 8.60% | 株式数 |
| VANGUARD GROUP INC | $78,353,343 | 4,288,634 | 6.73% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69,037,426 | 4,827,792 | 5.93% | 株式数 |
| Commodore Capital LP | $65,780,000 | 4,600,000 | 5.65% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $51,912,604 | 3,630,252 | 4.46% | 株式数 |
| JANUS HENDERSON GROUP PLC | $45,962,750 | 3,565,768 | 3.95% | 株式数 |
| Paradigm Biocapital Advisors LP | $41,332,677 | 2,890,397 | 3.55% | 株式数 |
| STATE STREET CORP | $33,712,894 | 2,357,545 | 2.90% | 株式数 |
| Aberdeen Group plc | $28,725,869 | 2,008,802 | 2.47% | 株式数 |
| PERCEPTIVE ADVISORS LLC | $28,600,000 | 2,000,000 | 2.46% | プットオプション |
| Balyasny Asset Management L.P. | $25,916,719 | 1,812,358 | 2.23% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $25,269,659 | 1,766,745 | 2.17% | 株式数 |
| CITADEL ADVISORS LLC | $25,214,389 | 1,763,244 | 2.17% | 株式数 |
| Parkman Healthcare Partners LLC | $18,420,731 | 1,288,163 | 1.58% | 株式数 |
| EVENTIDE ASSET MANAGEMENT, LLC | $17,811,837 | 1,245,583 | 1.53% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $16,890,345 | 1,181,143 | 1.45% | 株式数 |
| Essex Woodlands Management, Inc. | $15,513,455 | 1,084,857 | 1.33% | 株式数 |
| ORBIMED ADVISORS LLC | $15,288,802 | 1,069,147 | 1.31% | 株式数 |
| 5AM Venture Management, LLC | $15,015,000 | 1,050,000 | 1.29% | 株式数 |
| Rosalind Advisors, Inc. | $14,131,689 | 988,230 | 1.21% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13,885,500 | 971,014 | 1.19% | 株式数 |
| HSBC HOLDINGS PLC | $11,918,407 | 833,455 | 1.02% | 株式数 |
| Candriam S.C.A. | $11,254,258 | 787,769 | 0.97% | 株式数 |
| AMERIPRISE FINANCIAL INC | $11,087,640 | 775,357 | 0.95% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $11,062,981 | 773,635 | 0.95% | 株式数 |
| Artia Global Partners LP | $10,969,501 | 767,098 | 0.94% | 株式数 |
| Blue Owl Capital Holdings LP | $10,905,094 | 762,594 | 0.94% | 株式数 |
| Patient Square Capital LP | $10,296,000 | 720,000 | 0.88% | 株式数 |
| Principia Wealth Advisory, LLC | $9,696,346 | 530,725 | 0.83% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9,260,866 | 647,613 | 0.80% | 株式数 |
| Sio Capital Management, LLC | $8,910,759 | 623,130 | 0.77% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $7,996,789 | 559,216 | 0.69% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7,899,320 | 552,400 | 0.68% | コールオプション |
| Alyeska Investment Group, L.P. | $7,284,463 | 509,403 | 0.63% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $7,151,330 | 500,093 | 0.61% | 株式数 |
| Simplify Asset Management Inc. | $5,720,629 | 400,044 | 0.49% | 株式数 |
| Ikarian Capital, LLC | $5,296,720 | 370,400 | 0.46% | コールオプション |
| Ikarian Capital, LLC | $5,296,720 | 370,400 | 0.46% | プットオプション |
| Ghisallo Capital Management LLC | $5,005,000 | 350,000 | 0.43% | 株式数 |
| STEMPOINT CAPITAL LP | $4,840,135 | 338,471 | 0.42% | 株式数 |
| E Fund Management Co., Ltd. | $4,730,068 | 330,774 | 0.41% | 株式数 |
| Jump Financial, LLC | $4,586,825 | 320,757 | 0.39% | 株式数 |
| Bleichroeder LP | $4,526,165 | 316,515 | 0.39% | 株式数 |
| Woodline Partners LP | $4,296,621 | 300,463 | 0.37% | 株式数 |
| Eversept Partners, LP | $4,257,610 | 297,735 | 0.37% | 株式数 |
| GOLDMAN SACHS GROUP INC | $4,086,797 | 285,790 | 0.35% | 株式数 |
| Rock Springs Capital Management LP | $3,839,822 | 268,519 | 0.33% | 株式数 |
| CITIGROUP INC | $3,750,032 | 262,240 | 0.32% | 株式数 |
| MYDA Advisors LLC | $3,575,000 | 250,000 | 0.31% | 株式数 |
| AXA Investment Managers S.A. | $3,480,640 | 244,427 | 0.30% | 株式数 |
| UBS Group AG | $3,373,442 | 235,905 | 0.29% | 株式数 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3,342,639 | 233,751 | 0.29% | 株式数 |
| Schonfeld Strategic Advisors LLC | $3,285,853 | 229,780 | 0.28% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,038,750 | 212,500 | 0.26% | プットオプション |
| Propel Bio Management, LLC | $2,741,954 | 191,745 | 0.24% | 株式数 |
| Qube Research & Technologies Ltd | $2,704,159 | 189,102 | 0.23% | 株式数 |
| Walleye Capital LLC | $2,691,560 | 188,221 | 0.23% | 株式数 |
| Susquehanna Portfolio Strategies, LLC | $2,685,554 | 187,801 | 0.23% | 株式数 |
| BlackRock, Inc. | $2,649,890 | 185,307 | 0.23% | 株式数 |
| CITADEL ADVISORS LLC | $2,559,700 | 179,000 | 0.22% | プットオプション |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2,389,303 | 169,334 | 0.21% | 株式数 |
| HighVista Strategies LLC | $2,226,567 | 155,704 | 0.19% | 株式数 |
| Granahan Investment Management, LLC | $2,136,234 | 149,387 | 0.18% | 株式数 |
| Swiss National Bank | $2,034,890 | 142,300 | 0.17% | 株式数 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1,998,711 | 139,770 | 0.17% | 株式数 |
| PANAGORA ASSET MANAGEMENT INC | $1,890,660 | 132,214 | 0.16% | 株式数 |
| Corient Private Wealth LP | $1,827,526 | 127,799 | 0.16% | 株式数 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1,740,081 | 121,684 | 0.15% | 株式数 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,548,690 | 108,300 | 0.13% | コールオプション |
| BOOTHBAY FUND MANAGEMENT, LLC | $1,548,690 | 108,300 | 0.13% | プットオプション |
| DIADEMA PARTNERS LP | $1,520,090 | 106,300 | 0.13% | コールオプション |
| SILVERBACK ASSET MANAGEMENT LLC | $1,430,000 | 100,000 | 0.12% | コールオプション |
| Squarepoint Ops LLC | $1,401,429 | 98,002 | 0.12% | 株式数 |
| RHUMBLINE ADVISERS | $1,393,341 | 97,437 | 0.12% | 株式数 |
| CITADEL ADVISORS LLC | $1,357,070 | 94,900 | 0.12% | コールオプション |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,354,752 | 105,101 | 0.12% | 株式数 |
| ALGERT GLOBAL LLC | $1,129,557 | 78,990 | 0.10% | 株式数 |
| Waverly Advisors, LLC | $1,114,170 | 77,914 | 0.10% | 株式数 |
| Cinctive Capital Management LP | $1,037,923 | 72,582 | 0.09% | 株式数 |
| Caption Management, LLC | $1,036,750 | 72,500 | 0.09% | コールオプション |
| WELLINGTON MANAGEMENT GROUP LLP | $1,035,134 | 72,387 | 0.09% | 株式数 |
| GOLDMAN SACHS GROUP INC | $1,002,430 | 70,100 | 0.09% | コールオプション |
| DEUTSCHE BANK AG\ | $989,860 | 69,221 | 0.09% | 株式数 |
| Bank of New York Mellon Corp | $981,824 | 68,659 | 0.08% | 株式数 |
| WOODSTOCK CORP | $979,049 | 68,465 | 0.08% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $971,081 | 75,336 | 0.08% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $930,186 | 65,048 | 0.08% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865,708 | 60,539 | 0.07% | 株式数 |
| FOX RUN MANAGEMENT, L.L.C. | $836,950 | 58,528 | 0.07% | 株式数 |
| Y-Intercept (Hong Kong) Ltd | $732,017 | 51,190 | 0.06% | 株式数 |
| SILVERBACK ASSET MANAGEMENT LLC | $715,000 | 50,000 | 0.06% | 株式数 |
| JANE STREET GROUP, LLC | $715,000 | 50,000 | 0.06% | コールオプション |
| Erste Asset Management GmbH | $705,500 | 50,000 | 0.06% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $702,545 | 49,129 | 0.06% | 株式数 |
| Point72 Asset Management, L.P. | $694,608 | 48,574 | 0.06% | 株式数 |
| SBI Okasan Asset Management Co.Ltd. | $644,827 | 45,700 | 0.06% | 株式数 |
| MetLife Investment Management, LLC | $621,607 | 43,469 | 0.05% | 株式数 |
| JANE STREET GROUP, LLC | $597,954 | 41,815 | 0.05% | 株式数 |
| SCOTIA CAPITAL INC. | $597,039 | 41,751 | 0.05% | 株式数 |
企業インサイダー 25 人のインサイダー · 12人の役員 · 16人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 2026年7月10日 M | 9,594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 2018年10月12日 A | 211,700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 2016年3月18日 M | 450,741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 2018年8月1日 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 2008年9月10日 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 2026年6月30日 M | 0 | 0 | 2 | $-73,174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 2018年12月22日 M | 76,187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 2018年10月12日 F | 29,600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 2018年5月14日 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 2017年6月27日 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 2016年7月21日 A | 96,423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 2007年10月18日 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | 取締役 | 2026年8月18日 P | 49,100 | 1 | 0 | $52,258 |
| Wendy F Dicicco | 取締役 | 2026年1月2日 A | — | 0 | 0 | $0 |
| ANDO GORAN | 取締役 | 2026年1月2日 A | — | 0 | 0 | $0 |
| Fred Hassan | 取締役 | 2026年1月2日 A | — | 0 | 0 | $0 |
| Michael W Rogers | 取締役 | 2018年11月15日 M | 112,500 | 0 | 0 | $0 |
| John B. Landis | 取締役 | 2018年10月25日 A | — | 0 | 0 | $0 |
| David J Mazzo | 取締役 | 2018年9月6日 A | 138,000 | 0 | 0 | $0 |
| Douglas Evan Godshall | 取締役 | 2018年6月27日 M | 12,500 | 0 | 0 | $0 |
| James J Barry | 取締役 | 2018年5月7日 M | 12,500 | 0 | 0 | $0 |
| Kristine Peterson | 取締役 | 2017年12月15日 A | — | 0 | 0 | $0 |
| SAVAS PETER G | 取締役 | 2015年12月3日 A | — | 0 | 0 | $0 |
| Paul Hopper | 取締役 | 2013年12月18日 A | 10,000 | 0 | 0 | $0 |
| Katherine Woodthorpe | 取締役 | 2007年11月27日 A | — | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 5保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 提出書類 | 2023年12月8日 | — | 初回提出 | — | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2023年8月30日 | — | 初回提出 | — | SEC |
| Ocumension Therapeutics | 2021年1月22日 | — | 初回提出 | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 提出書類 | 2017年5月26日 | — | 初回提出 | — | SEC |
| Pfizer Inc. | 2007年7月17日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 42のETFが保有
ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1.18% | 11,564 NS | 2026年4月30日 | N-PORT |
| BBC · ETFis Series Trust I | 0.61% | 17,260 NS | 2026年4月30日 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.51% | 8,244 SH | 2026年8月8日 | 日次 |
| IWC · iShares Trust | 0.23% | 262,360 SH | 2026年8月8日 | 日次 |
| IHE · iShares Trust | 0.22% | 281,199 SH | 2026年8月8日 | 日次 |
| FSCC · Federated Hermes ETF Trust | 0.12% | 25,180 NS | 2026年5月31日 | N-PORT |
| NUSC · Nushares ETF Trust | 0.08% | 78,250 NS | 2026年4月30日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.08% | 4,561 SH | 2026年8月8日 | 日次 |
| VFMO · VANGUARD WELLINGTON FUND | 0.06% | 86,797 SH | 2026年8月8日 | 日次 |
| BIB · ProShares Trust | 0.06% | 3,062 NS | 2026年5月31日 | N-PORT |
| IWO · iShares Trust | 0.05% | 592,383 SH | 2026年8月8日 | 日次 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.05% | 69,310 SH | 2026年8月8日 | 日次 |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 25,575 NS | 2026年5月31日 | N-PORT |
| IWM · iShares Trust | 0.03% | 1,980,136 SH | 2026年8月8日 | 日次 |
| RSSL · Global X Funds | 0.03% | 33,518 NS | 2026年4月30日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 445,218 SH | 2026年8月8日 | 日次 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 61,360 SH | 2026年8月8日 | 日次 |
| ISCV · iShares Trust | 0.03% | 15,627 SH | 2026年8月8日 | 日次 |
| ITWO · ProShares Trust | 0.03% | 3,648 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.02% | 378,469 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 34,174 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.02% | 2,853 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 152,391 NS | 2026年4月30日 | N-PORT |
| ISCB · iShares Trust | 0.01% | 3,155 SH | 2026年8月8日 | 日次 |
| URTY · ProShares Trust | 0.01% | 2,885 NS | 2026年5月31日 | N-PORT |
| IWN · iShares Trust | 0.01% | 120,933 SH | 2026年8月8日 | 日次 |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 901,417 SH | 2026年8月8日 | 日次 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 11,210 SH | 2026年8月8日 | 日次 |
| VHT · VANGUARD WORLD FUND | 0.01% | 213,549 SH | 2026年8月8日 | 日次 |
| WSML · iShares Trust | 0.01% | 4,526 SH | 2026年8月8日 | 日次 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 2,895 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 72 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 28,026 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 3,564 NS | 2026年4月30日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 111,667 SH | 2026年8月8日 | 日次 |
| IWV · iShares Trust | 0.00% | 21,976 SH | 2026年8月8日 | 日次 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 46,188 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 10,667 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 41,879 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 13,282 NS | 2026年4月30日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,643,860 SH | 2026年8月8日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,035 SH | 2026年8月8日 | 日次 |